Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. - Wikidata - wikimedia - TriplyDB

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

http://www.wikidata.org/entity/Q33941199

about

Anti-TNF agents for paediatric psoriasis Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings Circulating Th17, Th22, and Th1 cells are increased in psoriasis Profile of secukinumab in the treatment of psoriasis: current perspectives Regulation of Dendritic Cell Function in Inflammation IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies Immunology of psoriasis Targeting of interleukin-17 in the treatment of psoriasis Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis The IL-17 pathway as a major therapeutic target in autoimmune diseases Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.Rationale and early clinical data on IL-17 blockade in psoriasis.CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice New insights in the immunologic basis of psoriasis.The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells.IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice.The role of IL-23 in the immunopathogenesis of psoriasis.Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis.CCL20/MIP-3 alpha mRNA expression in the conjunctival epithelium of normal individuals and patients with vernal keratoconjunctivitis.Foxo1 inhibits diabetic mucosal wound healing but enhances healing of normoglycemic wounds.CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.Epidermal keratinocytes initiate wound healing and pro-inflammatory immune responses following percutaneous schistosome infection Accelerated wound healing phenotype in Interleukin 12/23 deficient mice.Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents.

P2860

Q24187673-E13469B6-4306-444E-A768-83E10181171D Q24295487-B9D0AA34-DEEB-4D3F-AADE-F3FA55555F66 Q24623195-1510742C-1CEA-4E66-AB2D-851C73F304D9 Q24629315-84309B2E-FB12-4BC4-A388-1215CED26C5E Q26776303-32FEEEA0-841C-4612-89DD-97BC87BF5832 Q26800988-D90B9CCD-625C-4347-ADD4-63A3BDB447CA Q26830943-4944C474-2FA1-42F1-A373-6CC746336A5D Q26995800-3807497A-B29A-4634-B08F-410F074764CC Q27026324-BEE3EDF4-7E0B-4288-86D9-7165D1F6FCF3 Q27310377-B0AB9D6B-8229-46D6-9EE9-EDBF9FE6BEA5 Q27310680-A13A50A4-C82A-4BC5-85C9-C5FEEB3A85E3 Q27330505-B375F242-E4E7-47AB-A3A4-851096A4FB31 Q28300826-0A167C90-91A4-4E2D-978A-1290DB08A9CC Q28511472-54EFA9C1-D711-4CF5-A940-51CABABD2B18 Q28732143-47226B7F-C1F4-4C34-AA74-6ADA53459507 Q30251957-D18E295F-DC1F-4701-B384-61DD6E3EB78D Q30658185-C9BAF8AE-BF73-4837-BE29-29B742933690 Q33670321-A1187A87-FBDD-422C-87CA-E6E7090F4711 Q33769731-8DE4B18F-90C2-45C8-8783-3ED7D0AC9DE5 Q33815790-76CD60A3-F245-4820-BD8B-47BC00B88D45 Q33818216-DAA8CDBC-1A81-4159-A486-6F780469ABB6 Q33844869-C8A2AFE6-8DD9-45D8-B161-E44B7BA6CBF2 Q33867284-76259BA2-0B1E-4F7B-8EB0-BF2C5F9E4B00 Q34082705-35CA6387-2612-4FD0-8E03-CFCF9132400B Q34144256-FDBCB19F-0B69-4281-8BF7-7C7E54C71745 Q34175490-0503DF62-C23C-486E-8055-427AFFE38AA7 Q34188885-686D2701-624C-4BD6-A5DB-31D675CA7DE6 Q34200331-35A6CD00-742A-4A9C-A14B-6E6D41DA60F8 Q34222410-2D90C6EF-9E20-4FD5-8BDF-692646D32B22 Q34498834-611669B7-3DB9-431F-9C21-7D3CB2EFC008 Q34577633-8837E954-6B3E-4E37-B1E2-4923D4C11784 Q34762513-37A09DE1-F539-44AE-980D-68CA64C9CB98 Q34792558-4E2574C5-EBF3-478D-A21E-17E93AC9FBF2 Q35040958-C45C1F0A-1D3A-420D-AC58-F2853D5B2645 Q35105155-0360E0A0-C753-4D26-8F14-B7F66FC59A39 Q35195110-3A6D0F6C-0551-4CF7-A1DC-06548B533797 Q35812102-92137A94-9B1D-4D50-901E-B6D5E8005A2B Q35887417-90830667-AF78-4C51-B653-E135BD3A05C6 Q35920946-6CB99265-84E7-4AD5-8DC2-A218E136723B Q36098905-35F4D39A-6CA5-4FD2-AA5E-B0BCBAA64441

P2860

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

http://www.wikidata.org/entity/Q33941199

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@ast

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@en

type

label

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@ast

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@en

prefLabel

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@ast

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@en

P1433

Q33941199-78155C61-1644-453D-AE74-BBA5CA45BD12

P1476

Q33941199-38B6D856-DD84-4269-AA24-5F8AD12F1D56

P2093

Q33941199-06C95826-E998-4728-B126-B9000C497EC9

Q33941199-27B59F48-A826-4007-BD86-199994D6CF8B

Q33941199-28BA2F7A-600A-49FE-A576-2277332E9ECC

Q33941199-52980091-9E4C-4D99-ADA9-F2C8C51E2433

Q33941199-62771D7F-9978-4292-B3E9-947B90002180

Q33941199-653F10E6-D513-45DC-B373-5E0D988DCA21

Q33941199-69F939A1-F936-401A-8A25-8022CE83C6E1

Q33941199-DBFEE87B-DEF1-4AD7-96F9-DE23F9D81DE6

Q33941199-DF92FC04-0A18-4361-952D-B9C8CED1ECD0

Q33941199-EBE74948-3EC3-48D8-A377-4CAD5E3DF51B

P2860

Q33941199-13B59AEF-1C70-4E34-ACA7-88B808795AFE

Q33941199-27B3BF3F-8885-4E70-9501-0A6AD907814B

Q33941199-3D730937-7D76-4300-A803-1B91F35C3EDE

Q33941199-41D900E3-E59E-4CF9-892D-3E2D526C5E97

Q33941199-455A548C-250E-44BF-898F-25562E101558

Q33941199-48C50E34-51BF-46AD-936E-56440C2F3444

Q33941199-492333F7-425E-4F52-A1A9-FFB5ABE1C8D2

Q33941199-4A62E547-9103-451D-8450-41E5B235B783

Q33941199-4B6A6AB8-8945-42EB-91C3-C1B78EA0E29C

Q33941199-4DEDE29B-66DC-4F2B-80EA-6E3F78F5D095

P2888

Q33941199-33E541A6-F977-40F9-B197-CDAD072BC7C1

P304

Q33941199-1653680D-BE3E-447D-AFEC-79E5859DFC8D

P31

Q33941199-373D1D2E-C281-4465-AB17-8FE0B6C32224

P356

Q33941199-14228B02-D267-4055-862F-A3AE438F04C5

P407

Q33941199-A47958AD-0CCB-4685-8047-F8FE793B6B8F

P433

Q33941199-4EC60964-08DE-400C-B8C8-C4829B771814

P478

Q33941199-4AD03B39-9592-48FB-AFBB-B4696D41EE84

P577

Q33941199-107E3B28-FE36-40FA-ADC4-E2048186EE96

P5875

Q33941199-ABADA891-4177-4B5E-AAE4-E9CA95F22A39

P6179

Q33941199-3B578173-4121-48C6-8D0F-F95CF8E8DF69

P698

Q33941199-ACC3AB26-AE4C-4444-8897-B3FD6CE8C4F5

P932

Q33941199-F89EFCC3-4C97-4E3E-BFC8-311830A7772C

P356

P1433

Journal of Investigative Dermatology

P1476

Th17 cytokines stimulate CCL20 ...... ns for psoriasis pathogenesis.

@en

P2093

Andrew Blauvelt

http://www.w3.org/2001/XMLSchema#string

Changsheng Guo

http://www.w3.org/2001/XMLSchema#string

David Purdy

http://www.w3.org/2001/XMLSchema#string

Erin Fitch

http://www.w3.org/2001/XMLSchema#string

Erin G Harper

http://www.w3.org/2001/XMLSchema#string

Heather Rizzo

http://www.w3.org/2001/XMLSchema#string

Iliyana Skorcheva

http://www.w3.org/2001/XMLSchema#string

Joseph V Lillis

http://www.w3.org/2001/XMLSchema#string

Mihail Iordanov

http://www.w3.org/2001/XMLSchema#string

Stephen E Kurtz

http://www.w3.org/2001/XMLSchema#string

P2860

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

Phenotypic and functional features of human Th17 cells

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

P2888

P304

2175-2183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2009.65

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24209592

http://www.w3.org/2001/XMLSchema#string

P6179

1031709831

http://www.w3.org/2001/XMLSchema#string

P698

19295614

http://www.w3.org/2001/XMLSchema#string

P932

2892172

http://www.w3.org/2001/XMLSchema#string